Ibuprofen-loaded calcium phosphate granules: combination of innovative characterization methods to relate mechanical strength to drug location.
This paper studies the impact of the location of a drug substance on the physicochemical and mechanical properties of two types of calcium phosphate granules loaded with seven different contents of ibuprofen, ranging from 1.75% to 46%. These implantable agglomerates were produced by either low or high shear granulation. Unloaded Mi-Pro pellets presented higher sphericity and mechanical properties, but were slightly less porous than Kenwood granules (57.7% vs 61.2%). Nevertheless, the whole expected quantity of ibuprofen could be integrated into both types of granules. A combination of surface analysis, using near-infrared (NIR) spectroscopy coupling chemical imaging, and pellet porosity, by mercury intrusion measurements, allowed ibuprofen to be located. It was shown that, from 0% to 22% drug content, ibuprofen deposited simultaneously on the granule surface, as evidenced by the increase in surface NIR signal, and inside the pores, as highlighted by the decrease in pore volume. From 22%, porosity was almost filled, and additional drug substance coated the granule surfaces, leading to a large increase in the surface NIR signal. This coating was more regular for Mi-Pro pellets owing to their higher sphericity and greater surface deposition of drug substance. Unit crush tests using a microindenter revealed that ibuprofen loading enhanced the mechanical strength of granules, especially above 22% drug content, which was favorable to further application of the granules as a bone defect filler.
Chevalier
E
E
Université de Limoges, CNRS SPCTS UMR 6638, Faculté de Pharmacie, Laboratoire de Pharmacie Galénique, 2 rue du Dr Marcland, 87025 Limoges Cedex, France.
Viana
M
M
Cazalbou
S
S
Makein
L
L
Dubois
J
J
Chulia
D
D
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage; D002130:Calcium Phosphates / Q000737:chemistry*; D002626:Chemistry, Pharmaceutical / Q000379:methods; D004337:Drug Carriers / Q000737:chemistry*; D004339:Drug Compounding / Q000379:methods; D016503:Drug Delivery Systems; D007052:Ibuprofen / Q000008:administration & dosage*; D008422:Materials Testing; D008855:Microscopy, Electron, Scanning; D010316:Particle Size; D016062:Porosity; D012995:Solubility; D013314:Stress, Mechanical; D013499:Surface Properties; D013678:Technology, Pharmaceutical / Q000379:methods
D000894:Anti-Inflammatory Agents, Non-Steroidal; D002130:Calcium Phosphates; D004337:Drug Carriers; C020243:calcium phosphate; D007052:Ibuprofen